<DOC>
	<DOCNO>NCT00633685</DOCNO>
	<brief_summary>Three hundred ( 300 ) male female outpatient , 18 year age , enrol study determine whether fluoxetine use treatment Posttraumatic Stress Disorder soldier recently return combat exposure . There two phase study . In Phase I Fluoxetine + usual psychological care compare Placebo + usual psychological care 12-week period . Subsequently , Phase II subject offer opportunity enroll 20-week open-label trial Fluoxetine . If response inadequate , adjunctive treatment either buspirone bupropion offer . The investigational drug Fluoxetine , Buspirone Bupropion . All commercially available .</brief_summary>
	<brief_title>Predictors Treatment Response Fluoxetine PTSD Following Recent History War Zone Stress Exposure</brief_title>
	<detailed_description>While soldier exposed stress war-zone exhibit psychological resilience , one-fifth become psychological casualty war . The fact significant number soldier difficulty adapt life war exposure suggest need well-defined treatment effective cost-efficient . Currently , recommendation first-line pharmacological management Post-Traumatic Stress Disorder focus use selective serotonin re-uptake inhibitor ( SSRIs ) fluoxetine . Despite recommendation DoD/VA Clinical Practice Guidelines , study evaluate effectiveness medication patient recently exposure war-zone stressor . In fact , study Vietnam Era veterans show limited effectiveness SSRIs PTSD . In addition , limited information available understand factor influence whether particular soldier respond treatment SSRI . This study design determine whether fluoxetine effective treatment PTSD associate condition soldier recent war-zone exposure , well determine whether response SSRIs related severity trauma exposure PTSD symptom , psychological resilience , adequacy social support ( family , extra-military military ) , post-deployment stressor life adversity , degree cognitive impairment . After informed consent give , fluoxetine ( 150 subject ) placebo ( 150 subject ) administer 12 week dose 20 mg daily 60 mg daily active duty soldier already receive usual psychological care Resilience Restoration Center Carl R. Darnall Army Medical Center Ft . Hood . At conclusion initial phase study , participant receive fluoxetine dose 80 mg daily additional 20 week . All participant regularly monitor determine change PTSD symptom . If subject least 50 % improvement give 80 mg daily fluoxetine 4 week , randomly assign also receive either bupropion SR ( 150 mg daily ) buspirone ( 40 mg daily ) attempt amplify response fluoxetine . Statistical analysis use determine factor provide great influence response medication trial . Each subject ask receive physical exam , give medical history information , receive diagnostic interview prior participation study . After randomly assign treatment , subject interview questionnaire assessment week 2 , 4 , 6 , 8 , 12 , 16 , 20 , 24 , 28 32 . Based solely degree response measure PTSD Checklist ( questionnaire administer study visit ) , dosage study medication fluoxetine placebo capsule adjust pre-determined schedule .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Combat Disorders</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>1 . Veteran OEF/OIF war campaign violence exposure sufficient qualify diagnosis PTSD 2 . DSMIV diagnosis PostTraumatic Stress Disorder determine CAPS . 3 . Entry Total CAPS score least 65 4 . No exposure psychotropic medication except zolpidem least two week ( five week fluoxetine ) prior baseline assessment . 5 . If female , negative betahuman chorionic gonadotropin pregnancy test willing use oral contraceptive 1 . History intolerance fluoxetine 2 . History lack responsivity 60 mg daily dose fluoxetine 3 . Current past history Bipolar Disorder Schizophrenia 4 . Diagnosis Major Depressive Disorder , ObsessiveCompulsive Disorder , Other Anxiety Disorder , unless PTSD principal focus treatment onset PTSD precede concurrent disorder 5 . Significant history suicidal homicidal behavior/ideation 6 . Substance dependence past 6 month 7 . Serious general medical condition would risk patient able complete pharmacological trial fluoxetine 8 . Concomitant use antidepressant , antipsychotic mood stabilizer 9 . If female , pregnancy unwilling use oral contraceptive 10 . Participation another research drug trial within 30days enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Factors predict response</keyword>
	<keyword>Resilience</keyword>
	<keyword>Pharmacologic augmentation strategy</keyword>
</DOC>